A carregar...
Severe arthritis and tenosynovitis caused by immune checkpoint blockade therapy with pembrolizumab (anti-PD-1 antibody)
Pembrolizumab, a monoclonal antibody against the immune checkpoint receptor–programmed cell death protein 1, has proven clinical efficacy in melanoma and other solid tumors. It increases the body’s immune response against the tumor cells. However, because of an uninhibited immune system, immune-medi...
Na minha lista:
| Publicado no: | Proc (Bayl Univ Med Cent) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6650205/ https://ncbi.nlm.nih.gov/pubmed/31384207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2019.1588654 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|